Evidence map›Paper›PMID 34399888›Full record

ArticleeLife2021

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1.

Carolina Marques, Thomas Unterkircher, Paula Kroon, Barbara Oldrini, Annalisa Izzo, Yuliia Dramaretska, Roberto Ferrarese, Eva Kling, Oliver Schnell, Sven Nelander and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 125 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Carolina MarquesSeve Ballesteros Foundation Brain Tumor Group, Spanish National Cancer Research Centre, Madrid, Spain.ORCID 0000-0002-8308-5630
Thomas UnterkircherDepartment of Neurosurgery, Faculty of Medicine Freiburg, Freiburg, Germany.
Paula KroonSeve Ballesteros Foundation Brain Tumor Group, Spanish National Cancer Research Centre, Madrid, Spain.
Barbara OldriniSeve Ballesteros Foundation Brain Tumor Group, Spanish National Cancer Research Centre, Madrid, Spain.
Annalisa IzzoDepartment of Neurosurgery, Faculty of Medicine Freiburg, Freiburg, Germany.
Yuliia DramaretskaMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Roberto FerrareseDepartment of Neurosurgery, Faculty of Medicine Freiburg, Freiburg, Germany.
Eva KlingDepartment of Neurosurgery, Faculty of Medicine Freiburg, Freiburg, Germany.
Oliver SchnellDepartment of Neurosurgery, Faculty of Medicine Freiburg, Freiburg, Germany.
Sven NelanderDept of Immunology, Genetics and Pathology and Science for Life Laboratory, Uppsala University, Rudbecklaboratoriet, Uppsala, Sweden.ORCID 0000-0003-1758-1262
Erwin F WagnerGenes, Development, and Disease Group, Spanish National Cancer Research Centre, Madrid, Spain.
Latifa BakiriGenes, Development, and Disease Group, Spanish National Cancer Research Centre, Madrid, Spain.
Gaetano GargiuloMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Maria Stella CarroDepartment of Neurosurgery, Faculty of Medicine Freiburg, Freiburg, Germany.ORCID 0000-0002-8570-7691
Massimo SquatritoSeve Ballesteros Foundation Brain Tumor Group, Spanish National Cancer Research Centre, Madrid, Spain.ORCID 0000-0002-4593-3790
Spanish National Cancer Research Centre · ESUniversity of Freiburg · DEMax Delbrück Center · DEUppsala University · SE

Funding

European Research Council 714922
6 · The paper itself

Abstract

The molecular basis underlying glioblastoma (GBM) heterogeneity and plasticity is not fully understood. Using transcriptomic data of human patient-derived brain tumor stem cell lines (BTSCs), classified based on GBM-intrinsic signatures, we identify the AP-1 transcription factor

Indexed as

Gene Expression Regulation, NeoplasticBrain NeoplasmsCell Line, TumorFos-Related Antigen 1GlioblastomaHumansNeoplastic Stem CellsNeurofibromin 1Proto-Oncogene Proteins c-fosFos-Related Antigen 1Neurofibromin 1NF1 protein, humanProto-Oncogene Proteins c-foscancer biologyFOSL1FRA-1GBMhumanmesenchymalmouseNF1

Identifiers

PMID34399888
PMCPMC8370767
OpenAlexW3191535247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.